S H Park1, E J Videlock1, W Shih2, A P Presson3, E A Mayer1, L Chang1. 1. Oppenheimer Family Center for the Neurobiology of Stress and Resilience, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA. 2. Department of Biostatistics, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA. 3. Division of Epidemiology, Department of Internal Medicine, University of Utah, Salt Lake City, UT, USA.
Abstract
BACKGROUND: Early adverse life events (EALs) are associated with irritable bowel syndrome (IBS). Exposure to EALs as assessed by the Adverse Childhood Experiences (ACE) questionnaire is associated with greater disease prevalence, but ACE has not been studied in gastrointestinal disorders. Study aims were to: (i) Estimate the prevalence of EALs in the IBS patients using the ACE questionnaire; (ii) Determine correlations between ACE and Early Trauma Inventory Self Report-Short Form (ETI-SR) scores to confirm its validity in IBS; and (iii) Correlate ACE scores with IBS symptom severity. METHODS: A total of 148 IBS (73% women, mean age = 31 years) and 154 HCs (59% women, mean age = 30 years) completed the ACE and ETI-SR between June 2010 and April 2015. These surveys measured EALs before age 18 in the domains of physical, sexual, and emotional abuse, and general trauma. IBS and abdominal pain severity was measured by a 20-point scale (0 = none, 20 = worst symptoms). KEY RESULTS: The ACE score increased the odds of having IBS (odds ratio [OR] = 2.05, 95% confidence interval [CI]: 1.21-3.48, p = 0.008). Household mental illness (p < 0.001), emotional abuse (p = 0.004), and incarcerated household member (p = 0.019) were significant predictors of IBS. Adverse childhood experiences and ETI-SR scores were strongly correlated (r = 0.59, p < 0.001). ACE, but not ETI-SR, modestly correlated with IBS severity (r = 0.17, p = 0.036) and abdominal pain (r = 0.20, p = 0.015). CONCLUSIONS & INFERENCES: The ACE questionnaire is a useful instrument to measure EALs in IBS based on its use in large studies, its ability to measure prevalence across different EAL domains, and its correlation with symptom severity.
BACKGROUND: Early adverse life events (EALs) are associated with irritable bowel syndrome (IBS). Exposure to EALs as assessed by the Adverse Childhood Experiences (ACE) questionnaire is associated with greater disease prevalence, but ACE has not been studied in gastrointestinal disorders. Study aims were to: (i) Estimate the prevalence of EALs in the IBSpatients using the ACE questionnaire; (ii) Determine correlations between ACE and Early Trauma Inventory Self Report-Short Form (ETI-SR) scores to confirm its validity in IBS; and (iii) Correlate ACE scores with IBS symptom severity. METHODS: A total of 148 IBS (73% women, mean age = 31 years) and 154 HCs (59% women, mean age = 30 years) completed the ACE and ETI-SR between June 2010 and April 2015. These surveys measured EALs before age 18 in the domains of physical, sexual, and emotional abuse, and general trauma. IBS and abdominal pain severity was measured by a 20-point scale (0 = none, 20 = worst symptoms). KEY RESULTS: The ACE score increased the odds of having IBS (odds ratio [OR] = 2.05, 95% confidence interval [CI]: 1.21-3.48, p = 0.008). Household mental illness (p < 0.001), emotional abuse (p = 0.004), and incarcerated household member (p = 0.019) were significant predictors of IBS. Adverse childhood experiences and ETI-SR scores were strongly correlated (r = 0.59, p < 0.001). ACE, but not ETI-SR, modestly correlated with IBS severity (r = 0.17, p = 0.036) and abdominal pain (r = 0.20, p = 0.015). CONCLUSIONS & INFERENCES: The ACE questionnaire is a useful instrument to measure EALs in IBS based on its use in large studies, its ability to measure prevalence across different EAL domains, and its correlation with symptom severity.
Authors: Michelle G Craske; Kate B Wolitzky-Taylor; Jennifer Labus; Stephen Wu; Michael Frese; Emeran A Mayer; Bruce D Naliboff Journal: Behav Res Ther Date: 2011-04-19
Authors: Yehuda Ringel; Douglas A Drossman; Timothy G Turkington; Barbara Bradshaw; Thomas C Hawk; Shrikant Bangdiwala; R Edward Coleman; William E Whitehead Journal: Dig Dis Sci Date: 2003-09 Impact factor: 3.199
Authors: J S Labus; R Bolus; L Chang; I Wiklund; J Naesdal; E A Mayer; B D Naliboff Journal: Aliment Pharmacol Ther Date: 2004-07-01 Impact factor: 8.171
Authors: Arpana Gupta; Lisa Kilpatrick; Jennifer Labus; Kirsten Tillisch; Adam Braun; Jui-Yang Hong; Cody Ashe-McNalley; Bruce Naliboff; Emeran A Mayer Journal: Psychosom Med Date: 2014 Jul-Aug Impact factor: 4.312
Authors: Colleen H Parker; Bruce D Naliboff; Wendy Shih; Angela P Presson; Elizabeth J Videlock; Emeran A Mayer; Lin Chang Journal: Clin Gastroenterol Hepatol Date: 2019-01-04 Impact factor: 11.382
Authors: Kelcie M Witges; Charles N Bernstein; Kathryn A Sexton; Tracie Afifi; John R Walker; Zoann Nugent; Lisa M Lix Journal: Inflamm Bowel Dis Date: 2019-09-18 Impact factor: 5.325
Authors: Jonathon L McClain; Elvio A Mazzotta; Nidia Maradiaga; Natalia Duque-Wilckens; Iveta Grants; Alfred J Robison; Fievos L Christofi; Adam J Moeser; Brian D Gulbransen Journal: Am J Physiol Gastrointest Liver Physiol Date: 2020-09-30 Impact factor: 4.052
Authors: S H Park; B D Naliboff; W Shih; A P Presson; E J Videlock; T Ju; L Kilpatrick; A Gupta; E A Mayer; L Chang Journal: Neurogastroenterol Motil Date: 2017-07-18 Impact factor: 3.598